First drug approved for treatment of post-partum depression

First drug approved for treatment of post-partum depression

In a recent breakthrough, the Food and Drug Administration (FDA) approved the first drug for the treatment of post-partum depression (PPD). The new drug, brexanolone, will be manufactured by Sage Therapeutics, Inc. and will be marketed under the name Zulresso. This is likely to open floodgates to treatment addressing this debilitating concern which is one of the most common complications post pregnancy.

[…] Read more